Cara Therapeutics Company Profile (NASDAQ:CARA)

About Cara Therapeutics

Cara Therapeutics logoCara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. The Company is engaged in developing product candidates that focus on the body's peripheral nervous system. Its product candidate pipeline includes I.V. CR845 for acute pain; I.V. CR845 for uremic pruritus; Oral CR845, and CR701. The Company's I.V. CR845 is an injectable version of peripheral kappa opioid receptor agonist, which is intended for the treatment of acute pain in an acute care setting. The Company is developing an oral version of CR845 for the treatment of moderate-to-severe acute and chronic pain. The Company's CR701 is a peripherally-restricted, mixed-CB1/CB2 receptor agonist that interacts with cannabinoid receptor subtypes, with no off-target activities. CR701 is in preclinical-stage of development.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CARA
  • CUSIP:
Key Metrics:
  • Previous Close: $5.51
  • 50 Day Moving Average: $5.68
  • 200 Day Moving Average: $5.96
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.85
  • P/E Growth: 0.00
  • Market Cap: $150.32M
  • Outstanding Shares: 27,282,000
  • Beta: 2.99
Additional Links:
Companies Related to Cara Therapeutics:

Analyst Ratings

Consensus Ratings for Cara Therapeutics (NASDAQ:CARA) (?)
Ratings Breakdown: 7 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $23.29 (318.81% upside)

Analysts' Ratings History for Cara Therapeutics (NASDAQ:CARA)
Show:
DateFirmActionRatingPrice TargetDetails
8/11/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details
8/7/2016Needham & Company LLCLower Price TargetBuy$27.00 -> $23.00View Rating Details
8/5/2016Stifel NicolausLower Price TargetBuy$25.00 -> $24.00View Rating Details
5/6/2016Canaccord GenuityReiterated RatingBuy$30.00View Rating Details
4/23/2016Piper Jaffray Cos.Reiterated RatingOverweight$23.00View Rating Details
3/12/2016Janney Montgomery ScottReiterated RatingBuy$23.00 -> $18.00View Rating Details
2/29/2016LaidlawLower Price TargetBuy$30.00 -> $17.00View Rating Details
3/3/2015MLV & Co.Initiated CoverageBuy$26.00View Rating Details
12/9/2014Summer StreetInitiated CoverageBuy$20.00View Rating Details
(Data available from 8/25/2014 forward)

Earnings

Earnings History for Cara Therapeutics (NASDAQ:CARA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/4/2016Q216($0.42)($0.48)$0.13 million$0.08 millionViewN/AView Earnings Details
5/5/2016Q116($0.40)($0.39)$0.03 million$0.01 millionViewN/AView Earnings Details
3/10/2016Q4($0.33)($0.35)$0.53 millionViewListenView Earnings Details
11/9/2015Q315($0.27)($0.19)$1.86 million$2.40 millionViewN/AView Earnings Details
8/10/2015Q215($0.24)($0.25)ViewListenView Earnings Details
5/12/2015Q415($0.27)($0.21)$0.70 million$0.50 millionViewListenView Earnings Details
3/26/2015Q4($0.30)($0.18)$0.91 millionViewListenView Earnings Details
11/10/2014Q314($0.22)($0.29)$0.13 million$1.13 millionViewN/AView Earnings Details
8/7/2014Q2($0.27)($0.16)$0.08 million$0.96 millionViewN/AView Earnings Details
5/12/2014Q1($0.14)($0.22)$0.30 million$0.18 millionViewN/AView Earnings Details
3/27/2014($0.18)($0.49)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cara Therapeutics (NASDAQ:CARA)
Current Year EPS Consensus Estimate: $-1.81 EPS
Next Year EPS Consensus Estimate: $-1.95 EPS

Dividends

Dividend History for Cara Therapeutics (NASDAQ:CARA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cara Therapeutics (NASDAQ:CARA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/20/2016Frederique Ph.D. MenzaghiVPSell6,000$9.00$54,000.00View SEC Filing  
3/17/2016Ventures Vi Lp RhoMajor ShareholderBuy400,000$4.87$1,948,000.00View SEC Filing  
2/3/2016Frederique Ph.D. MenzaghiVPSell6,000$9.04$54,240.00View SEC Filing  
1/26/2016Michael E LewisInsiderSell7,262$10.93$79,373.66View SEC Filing  
1/6/2016Derek T ChalmersCEOSell12,500$17.22$215,250.00View SEC Filing  
12/1/2015Frederique Ph.D. MenzaghiVPSell6,000$16.21$97,260.00View SEC Filing  
11/2/2015Frederique Ph.D. MenzaghiVPSell6,000$14.26$85,560.00View SEC Filing  
10/1/2015Frederique Ph.D. MenzaghiVPSell6,000$13.95$83,700.00View SEC Filing  
9/1/2015Frederique Ph.D. MenzaghiVPSell7,000$18.63$130,410.00View SEC Filing  
8/18/2015Josef SchoellCFOBuy3,000$22.10$66,300.00View SEC Filing  
6/1/2015Michael E LewisInsiderSell7,262$9.50$68,989.00View SEC Filing  
5/19/2015Dean SlagelDirectorSell188,811$10.02$1,891,886.22View SEC Filing  
4/1/2015Michael E LewisInsiderSell7,262$9.90$71,893.80View SEC Filing  
3/2/2015Michael E LewisInsiderSell7,262$10.11$73,418.82View SEC Filing  
2/2/2015Michael E LewisInsiderSell7,262$10.60$76,977.20View SEC Filing  
2/5/2014Ventures Vi Lp RhoMajor ShareholderBuy225,818$11.00$2,483,998.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cara Therapeutics (NASDAQ:CARA)
DateHeadline
prnewswire.com logoDiversity of the Legal and Medical Marijuana Markets (NASDAQ:CARA)
www.prnewswire.com - August 24 at 12:18 PM
4-traders.com logoZynerba Pharmaceuticals : Diversity of the Legal and Medical Marijuana Markets (NASDAQ:CARA)
www.4-traders.com - August 24 at 12:18 PM
live-pr.com logoNewly released market study: Cara Therapeutics, Inc. (CARA) - Financial and Strategic SWOT Analysis Review (NASDAQ:CARA)
www.live-pr.com - August 24 at 12:18 PM
prnewswire.com logoThe Growth of the Legal and Medical Marijuana Markets (NASDAQ:CARA)
www.prnewswire.com - August 23 at 4:11 PM
investornewswire.com logoCara Therapeutics, Inc. (NASDAQ:CARA) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:CARA)
www.investornewswire.com - August 23 at 8:13 AM
News IconCara Therapeutics Inc (NASDAQ:CARA)’s CR845 Could Be A Game Changer In Pain Management (NASDAQ:CARA)
streetregister.com - August 17 at 4:10 PM
News IconCara Therapeutics Inc (NASDAQ:CARA)'s CR845 Could Be A Game Changer In Pain Management - Street Register (NASDAQ:CARA)
streetregister.com - August 17 at 12:14 PM
News IconDetailed examination of the hyperalgesia pipeline market report - identify diverse types of therapeutics under development, H2 2016 (NASDAQ:CARA)
www.whatech.com - August 16 at 4:07 PM
capitalcube.com logoETF’s with exposure to CARA Therapeutics, Inc. : August 16, 2016 (NASDAQ:CARA)
www.capitalcube.com - August 16 at 4:07 PM
investornewswire.com logoWill Cara Therapeutics, Inc. (NASDAQ:CARA) Hit $24 Price Target? - Investor Newswire (NASDAQ:CARA)
www.investornewswire.com - August 15 at 9:41 PM
capitalcube.com logoCARA Therapeutics, Inc. :CARA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:CARA)
www.capitalcube.com - August 15 at 4:12 PM
finance.yahoo.com logoCARA THERAPEUTICS, INC. Financials (NASDAQ:CARA)
finance.yahoo.com - August 12 at 4:05 PM
News IconHC Stocks Judgment: Array Biopharma Inc (NASDAQ:ARRY), Cara Therapeutics Inc (NASDAQ:CARA) - share market updates (press release) (NASDAQ:CARA)
sharemarketupdates.com - August 8 at 9:29 PM
fortune.com logoThe Insider Activity Don't Lie: Cara Therapeutics Inc. (NASDAQ:CARA) - Review Fortune (NASDAQ:CARA)
reviewfortune.com - August 8 at 9:29 PM
News IconLockheed Martin (NYSE:LMT) & Cara Therapeutics Inc (NASDAQ:CARA) Stock's Buzzers - Money News (press release) (NASDAQ:CARA)
www.newsismoney.com - August 8 at 9:29 PM
twst.com logoCARA Therapeutics Inc.: Cara Therapeutics Reports Second Quarter 2016 Financial Results - The Wall Street Transcript (NASDAQ:CARA)
www.twst.com - August 6 at 4:31 PM
reuters.com logoBRIEF-Cara therapeutics posts Q2 shr loss $0.48 - Reuters (NASDAQ:CARA)
www.reuters.com - August 5 at 4:05 PM
twst.com logoCARA Therapeutics Inc.: Cara Therapeutics Reports Second Quarter 2016 Financial Results (NASDAQ:CARA)
www.twst.com - August 4 at 9:47 PM
sg.finance.yahoo.com logoCara reports 2Q loss (NASDAQ:CARA)
sg.finance.yahoo.com - August 4 at 9:47 PM
finance.yahoo.com logoCara Therapeutics Reports Second Quarter 2016 Financial Results (NASDAQ:CARA)
finance.yahoo.com - August 4 at 4:12 PM
equities.com logoCara Therapeutics Inc. (CARA) Jumps 5.19% on August 03 - Equities.com (NASDAQ:CARA)
www.equities.com - August 3 at 9:45 PM
equities.com logoCara Therapeutics Inc. (CARA) Jumps 6.15% on July 27 - Equities.com (NASDAQ:CARA)
www.equities.com - July 29 at 6:01 AM
publicnow.com logoCara Therapeutics to Announce Second Quarter 2016 Financial Results on August 4, 2016 (NASDAQ:CARA)
www.publicnow.com - July 28 at 8:18 AM
streetupdates.com logoTwo Movers within Analysts Observation: Cara Therapeutics, Inc. (NASDAQ:CARA) , Globus Medical, Inc. (NYSE:GMED) - Street Updates (NASDAQ:CARA)
www.streetupdates.com - July 26 at 9:26 AM
forbes.com logoSix Major Biotech Acquisitions You Could See in 2016 (Part 3) (NASDAQ:CARA)
www.forbes.com - July 26 at 9:00 AM
News IconMix Wondering Stocks- Valeant Pharmaceuticals International (NYSE:VRX), Cara Therapeutics (NASDAQ:CARA ... - Seneca Globe (NASDAQ:CARA)
www.senecaglobe.com - July 25 at 10:09 PM
investornewswire.com logoCan Shares Of Cara Therapeutics, Inc. (NASDAQ:CARA) Hit $25? - Investor Newswire (NASDAQ:CARA)
www.investornewswire.com - July 25 at 4:37 PM
investornewswire.com logoCan Shares Of Cara Therapeutics, Inc. (NASDAQ:CARA) Hit $25? - Investor Newswire (NASDAQ:CARA)
www.investornewswire.com - July 25 at 4:37 PM
kcregister.com logoBiotech Volatile Stocks: Lpath Inc. (NASDAQ:LPTN), Cara Therapeutics Inc. (NASDAQ:CARA), Galena Biopharma Inc ... - KC Register (NASDAQ:CARA)
www.kcregister.com - July 25 at 4:37 PM
kcregister.com logoBiotech Volatile Stocks: Lpath Inc. (NASDAQ:LPTN), Cara Therapeutics Inc. (NASDAQ:CARA), Galena Biopharma Inc ... - KC Register (NASDAQ:CARA)
www.kcregister.com - July 25 at 4:37 PM
streetupdates.com logoAnalysts Suggestion Alert: Cara Therapeutics, Inc. (NASDAQ:CARA ... - Street Updates (NASDAQ:CARA)
www.streetupdates.com - July 25 at 4:37 PM
fortune.com logoCara Therapeutics Inc. (NASDAQ:CARA) Insiders Seem Vary About ... - Review Fortune (NASDAQ:CARA)
reviewfortune.com - July 25 at 4:37 PM
News IconHC Stocks to Path: CIGNA Corporation (NYSE:CI) Cara ... - share market updates (press release) (NASDAQ:CARA)
sharemarketupdates.com - July 25 at 4:37 PM
fxpips.com logoBiggest Moving Stocks Pre Market – TCCO, CADC, TOPS, SPU, CARA, EVK, SMIT (NASDAQ:CARA)
www.fxpips.com - July 25 at 8:51 AM
News IconPrice Target Estimates: Cara Therapeutics Inc. (NASDAQ:CARA) - News Oracle (NASDAQ:CARA)
www.newsoracle.com - July 24 at 8:44 AM
equities.com logoCara Therapeutics Inc. (CARA) Jumps 21.8% on July 22 - Equities.com (NASDAQ:CARA)
www.equities.com - July 23 at 8:22 AM
schaeffersresearch.com logoCara Therapeutics Inc (CARA) Bull Gap Draws Options Traders - Schaeffers Research (blog) (NASDAQ:CARA)
www.schaeffersresearch.com - July 23 at 8:22 AM
schaeffersresearch.com logoCara Therapeutics Inc (CARA) Bull Gap Draws Options Traders (NASDAQ:CARA)
www.schaeffersresearch.com - July 22 at 4:07 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Cara Therapeutics, Inc. (NASDAQ:CARA) - TGP (NASDAQ:CARA)
telanaganapress.com - July 22 at 12:13 PM
News IconStock Moving Lower for the Month; Investor Update on Cara Therapeutics Inc. (NASDAQ:CARA) - Engelwood Daily (NASDAQ:CARA)
www.engelwooddaily.com - July 21 at 8:22 AM
News IconCould Cara Therapeutics Inc Lose Strenght? The Stock Increases A Lot Today - Press Telegraph (NASDAQ:CARA)
presstelegraph.com - July 20 at 11:22 PM
sbwire.com logoPruritus Therapeutics Market Size and Key Trends in Terms of Volume and Value 2020 (NASDAQ:CARA)
www.sbwire.com - July 20 at 12:03 PM
News IconCara Therapeutics Incorporated (NASDAQ:CARA) Shorted Shares Increased By 39.33% - Consumer Eagle (NASDAQ:CARA)
www.consumereagle.com - July 19 at 9:25 PM
News IconCara Therapeutics, Inc. (NASDAQ:CARA): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:CARA)
www.engelwooddaily.com - July 19 at 4:06 PM
News IconTrading Performance and Target Watch for Cara Therapeutics, Inc. (NASDAQ:CARA) - Press Telegraph (NASDAQ:CARA)
presstelegraph.com - July 19 at 10:18 AM
investornewswire.com logoIs $25 Price Target Attainable For Cara Therapeutics, Inc. (NASDAQ:CARA)? - Investor Newswire (NASDAQ:CARA)
www.investornewswire.com - July 19 at 10:18 AM
News IconShares Moving Down on the Week: Cara Therapeutics Inc. (NASDAQ:CARA) - Engelwood Daily (NASDAQ:CARA)
www.engelwooddaily.com - July 17 at 8:42 AM
News IconHow Analysts Rated Cara Therapeutics Inc (NASDAQ:CARA) Last Week? - Consumer Eagle (NASDAQ:CARA)
www.consumereagle.com - July 17 at 8:42 AM
News IconShares Experiencing a Downtrend: Cara Therapeutics Inc. (NASDAQ:CARA) - TGP (NASDAQ:CARA)
telanaganapress.com - July 15 at 7:37 PM
globenewswire.com logoCara Therapeutics' Data to be Presented at the British Association for Psychopharmacology 2016 Summer Meeting - GlobeNewswire (press release) (NASDAQ:CARA)
globenewswire.com - July 15 at 7:37 PM

Social

Cara Therapeutics (NASDAQ:CARA) Chart for Thursday, August, 25, 2016


Last Updated on 8/25/2016 by MarketBeat.com Staff